Back to top

View the PFP Archive

Plus 5 New Strong Buys for Today
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research

Stocks Rebounded Sharply On Monday

Stocks rebounded sharply from Friday's sell-off. The Nasdaq led the way yesterday with a gain of 1.88%, followed by the S&P with 1.32%, and the Dow with 0.68%. The small-cap Russell 2000, however, was not able to maintain their intraday gains, giving up -0.18% by the close.

News on Friday that a new Covid variant, called omicron, sank stocks. The new strain is thought to be more transmissible and possibly vaccine resistant.

But while it is still considered more transmissible, some reports have suggested the symptoms are milder. And other reports have suggested that the vaccines indeed are believed to offer protection.

It will take weeks, however, to understand the severity of this new variant and how to properly fight it.

Until then, numerous countries, including the U.S., have restricted travel to and from South Africa.

But the administration yesterday said there was no need for lockdowns, and no need for any additional travel restrictions. And the markets extended their gains on the news.

Moreover, vaccine makers have said if adjustments are needed to combat this new strain, they were confident they could create a new one within 6 weeks and make/ship it out within 100 days.

In the meantime, stocks are likely to remain volatile.

But at the moment, omicron does not look like it will derail the economic rebound. And with GDP expected to accelerate into the end of the year, it looks like there's plenty more upside to go. Especially with December typically being a strong month for stocks.

See you tomorrow,

Kevin Matras

Executive Vice President, Zacks Investment Research


Why Haven't You Looked at Zacks' Top Stocks?

Our 5 best-performing strategies have blown away the S&P's impressive +103.9% gain from 2016 through 2020. Amazingly, they soared +381.1%, +424.1%, +429.0%, +477.8%, and even +580.0%.

Today you can access their live picks without cost or obligation.

See Stocks Free >>

Most Popular Articles from

Image: Bigstock

Omicron Fears Fuel Rally in Vaccine Stocks: Will It Continue?

Several mutations of this variant spark fears of high resistance to the COVID-19 vaccines. Read More »

Image: Bigstock

3 Communication Stocks Set to Beat the Chip Shortage Blues

The Coronavirus-driven digital transformation and accelerated pace of 5G deployment should help the industry thrive despite short-term headwinds. Read More »

Image: Bigstock

Add These 3 Cyber Monday Software Charts to Your Watchlist

These three companies, within the Internet-Software group, are setting the stage for a stellar 2022. Read More »

Image: Bigstock

Buy These 2 Stocks Before December Earnings?

Here are two modern retail stocks that investors should consider buying. Read More »

Image: Bigstock

7 Multiline Insurers to Watch As Business Activity Gains Momentum

Better pricing, product redesigns, advancement in tech along with optimistic growth outlooks are expected to aid these multiline insurers. Read More »


Your Exclusive Access to Today's Top ETFs

Use Zacks ETF Rank to help you select the very best ETFs for your portfolio. This quantitative ratings system takes into account asset class forecasts as well as several ETF-specific factors. All to give you a comprehensive account of a fund's potential before you invest your money.

See Today's Top-Ranked ETFs >>

Image: Bigstock

Bull of the Day: Tyson Foods (TSN)

Don't be chicken with this stock as we head into 2022. Read More »

New Zacks Strong Buys for November 30th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »


Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.